US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about MM/120

Recent news which mentions MM/120

MindMed's Phase 2b Trial For MM-120 In GAD Reaches Enrollment Milestone
Tickers MNMD
Tags MNMD Generalized Anxiety Disorder Benzinga
From Benzinga
MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes
Tickers MNMD OPNT
Tags OPNT MNMD Robert Barrow
From Benzinga